Aarkstore - Glycine Reuptake Inhibitors (GlyRI) -Pipeline Insights, 2014

1
Glycine Reuptake Inhibitors (GlyRI) -Pipeline
Insights, 2014
Category Pharmaceuticals Healthcare

• Browse Complete Report -
• http//www.aarkstore.com/pharmaceuticals-healthcar
  e/73730/glycine-reuptake-inhibitors-glyri-pipeline
  -insights-2014

2
Summary

• DelveInsights,Glycine Reuptake Inhibitors
  (GlyRI)-Pipeline Insights, 2014, report provides
  comprehensive insights about pipeline drugs
  across this mechanism of action (MOA). A key
  objective of the report is to establish the
  understanding for all the pipeline drugs that
  fall under Glycine Reuptake Inhibitors (GlyRI).
  This report provides information on the
  therapeutic development based on the Glycine
  Reuptake Inhibitors (GlyRI) dealing with
  mechanism of action, comparative analysis at
  various stages covering Filed, Phase III, Phase
  II, Phase I, IND filed, Preclinical, Discovery
  and unknown stages, therapeutics assessment by
  monotherapy and combination products and molecule
  type drug information. The report also covers the
  companies information involved in the therapeutic
  development of the products. It also has
  highlighted the discontinued and dormant products.

3
Summary

• Data Sources
• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.Secondary
  sources information and data has been collected
  from various printable and non-printable sources
  like search engines, News websites, Government
  Websites, Trade Journals, White papers,
  Magazines, Trade associations, Books, Industry
  Portals, Industry Associations and access to
  available databases.Please note this report
  requires certain updates. We have all the
  information available but require 3 business days
  to complete the process and ensure it is as
  up-to-date as possible. Certain sections in the
  report may be removed or altered based on the
  availability and relevance of data for the
  indicated mechanism of action. 

4
Summary

• Scope 
• The report provides a snapshot of the global
  therapeutic landscape of Glycine Reuptake
  Inhibitors (GlyRI)The report provides pipeline
  products under drug profile section which
  includes product description, MOA, licensors
  collaborators, development partner and chemical
  informationCoverage of the Glycine Reuptake
  Inhibitors (GlyRI) pipeline on the basis of
  target, MOA, route of administration, technology
  involved and molecule typeThe report reviews key
  players involved in the therapeutics development
  for Glycine Reuptake Inhibitors (GlyRI) and also
  provide company profilingThe report also gives
  the information of dormant and discontinued
  pipeline projects Pipeline products coverage
  based on various stages of development ranging
  from preregistration till discovery and
  undisclosed stages Provides pipeline assessment
  by monotherapy and combination therapy products,
  stage of development and molecule type

5
Summary

• Reasons to buyComplete MOA intelligence and
  complete understanding over therapeutics
  development for Glycine Reuptake Inhibitors
  (GlyRI)Identify the relationship between the
  drugs and use it for target finding, drug
  repurposing, and precision medicine.Devise
  corrective measures for pipeline projects by
  understanding Glycine Reuptake Inhibitors (GlyRI)
  pipeline depth and focus of Indication
  therapeutics Developing strategic initiatives to
  support your drug development activities.Optimize
  your portfolio and keep you in touch with the
  rapidly changing pharmaceutical markets, and make
  the best decisions for your business.

6
Summary

• Develop and design in licensing and out licensing
  strategies by identifying prospective partners
  with the most attractive projects to enhance and
  expand business potential and ScopeProvides
  strategically significant competitor information,
  analysis, and insights to formulate effective RD
  development strategies Modify the therapeutic
  portfolio by identifying discontinued projects
  and understanding the factors that drove them
  from pipelineGaining a Full Picture of the
  Competitive Landscape for Evidence based Decisions

7
Table of Content

• Glycine Reuptake Inhibitors (GlyRI)
  OverviewGlycine Reuptake Inhibitors (GlyRI)
  Disease AssociatedGlycine Reuptake Inhibitors
  (GlyRI) Pipeline TherapeuticsGlycine Reuptake
  Inhibitors (GlyRI) Therapeutics under Development
  by Companies Glycine Reuptake Inhibitors (GlyRI)
  Late Stage Products (Filed and Phase
  III)Comparative Analysis Glycine Reuptake
  Inhibitors (GlyRI) Mid Clinical Stage Products
  (Phase II)Comparative Analysis Glycine Reuptake
  Inhibitors (GlyRI) Early Clinical Stage Products
  (Phase I and IND Filed)Comparative
  Analysis Glycine Reuptake Inhibitors (GlyRI)
  Discovery and Pre-Clinical Stage
  Products Comparative Analysis Drug Candidate
  Profiles

8
Table of Content

• Glycine Reuptake Inhibitors (GlyRI) Therapeutics
  Assessment Assessment by Monotherapy
  Products Assessment by Combination
  Products Assessment by Route of
  Administration Assessment by Molecule
  Type Glycine Reuptake Inhibitors (GlyRI)
  Discontinued Products Glycine Reuptake
  Inhibitors (GlyRI) Dormant ProductsCompanies
  Involved in Therapeutics Development for Glycine
  Reuptake Inhibitors (GlyRI) Appendix Methodology
   Contact Us Disclaimer

9
List of Tables

• Number of Products under Development for Glycine
  Reuptake Inhibitors (GlyRI) by Therapy Area,
  2014Number of Products under Development for
  Glycine Reuptake Inhibitors (GlyRI), 2014Number
  of Products under Development by
  Companies Comparative Analysis by Late Clinical
  Stage Products (Filed and Phase III),
  2014Comparative Analysis Mid Clinical Stage
  Products (Phase II), 2014Comparative Analysis
  Early Clinical Stage Products (Phase I and IND
  Filed), 2014Comparative Analysis Discovery and
  Pre-Clinical Stage Products, 2014Drug Candidates
  Profiles

10
List of Tables

• Glycine Reuptake Inhibitors (GlyRI) Assessment by
  Monotherapy Products Glycine Reuptake Inhibitors
  (GlyRI) Assessment by Combination
  Products Glycine Reuptake Inhibitors (GlyRI)
  Assessment by Route of Administration Glycine
  Reuptake Inhibitors (GlyRI) Assessment by Stage
  and Route of Administration Glycine Reuptake
  Inhibitors (GlyRI) Assessment by Molecule
  Type Glycine Reuptake Inhibitors (GlyRI)
  Assessment by Stage and Molecule Type Glycine
  Reuptake Inhibitors (GlyRI) Therapeutics
  Discontinued Products Glycine Reuptake
  Inhibitors (GlyRI) Therapeutics Dormant
  ProductsProducts under Development by Companies,
  2014

11
List of Figures

• Number of Products under Development for Glycine
  Reuptake Inhibitors (GlyRI) by Therapy Area,
  2014Number of Products under Development for
  Glycine Reuptake Inhibitors (GlyRI), 2014Late
  Clinical Stage Products (Filed and Phase III),
  2014Mid Clinical Stage Products (Phase II),
  2014Early Clinical Stage Products (Phase I and
  IND Filed), 2014Discovery and Pre-Clinical Stage
  Products, 2014Glycine Reuptake Inhibitors
  (GlyRI) Assessment by Monotherapy
  Products Glycine Reuptake Inhibitors (GlyRI)
  Assessment by Combination Products Glycine
  Reuptake Inhibitors (GlyRI) Assessment by Route
  of Administration Glycine Reuptake Inhibitors
  (GlyRI) Assessment by Stage and Route of
  Administration Glycine Reuptake Inhibitors
  (GlyRI) Assessment by Molecule Type Glycine
  Reuptake Inhibitors (GlyRI) Assessment by Stage
  and Molecule Type

12
Related Reports

• The Mobile Healthcare (mHealth) Bible 2014 -
  2020
• Pregnancy Detection Kit Market in the US
  2015-2019
• Global Prenatal and Newborn Genetic Testing
  Market 2015-2019
• Global Knee Implant market 2015-2019
• Global Isosorbide Market 2015-2019
• Ascension Health - Pharmaceuticals Healthcare -
  Deals and Alliances Profile
• Accretive Health, Inc. (ACHI) - Strategic SWOT
  Analysis Review
• Jazz Pharmaceuticals plc (JAZZ) - Financial and
  Strategic SWOT Analysis Review
• Pharmstandard (PHST) - Financial and Strategic
  SWOT Analysis Review
• GLG Life Tech Corporation (GLG) - Financial and
  Strategic SWOT Analysis Review

13

• Glycine Reuptake Inhibitors (GlyRI) -Pipeline
  Insights, 2014
• Published Dec. 2014 60 Pages
• DelveInsights,Glycine Reuptake Inhibitors
  (GlyRI)-Pipeline Insights, 2014, report provides
  comprehensive insights about pipeline drugs
  across this mechanism of action (MOA).
  Price

Format Price
PDF 1250
Site Licence 2500
Enterprise Wide Licence 4000
14
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news